Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1835022 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $3.87Day −3.25%Mkt cap $91M1Y −39.5%Off 52W high −50.1%Vol (1Y) 65.2%
Daily closing price, split-adjusted to the current basis; 3y shown of 894 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest4.5% of sh out |
| Days to cover3.5d |
| 13F net flow (QoQ)+2.31% |
| Top-10 13F concentration82.9% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$7.9M |
| Earnings (TTM)-$21.1M |
| ROE−51.4% |
| Net margin−267.1% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−33.3% |
| 1Y−39.5% |
| 3Y−2.8% |
| Since incept. (ann.)−4.5% |
Total return through 2026-07-29 · series begins 2022-12-29. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)65.2% |
| Ann. volatility (3Y)72.3% |
| Sharpe (1Y)−0.51 |
| Sharpe (3Y)0.34 |
| Max drawdown (1Y)−48.6% |
| Max drawdown (3Y)−62.9% |
| Beta (3Y vs SPY)1.00 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| DME Capital Management, LP | 2.3M | $9M | 9.96% | +15.3% |
| AIGH Capital Management LLC | 975,404 | $4M | 4.16% | +0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 844,913 | $3M | 3.60% | new |
| Alyeska Investment Group, L.P. | 800,000 | $3M | 3.41% | +0.0% |
| Prosight Management, LP | 420,360 | $2M | 1.79% | new |
| CM Management, LLC | 375,000 | $1M | 1.60% | +7.1% |
| PRIVATE MANAGEMENT GROUP INC | 369,096 | $1M | 1.57% | +31.7% |
| GEODE CAPITAL MANAGEMENT, LLC | 233,402 | $919,783 | 1.00% | +17.9% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-12 | −$0.32 | — | $251,147 | −2.6% |
| 2025-12-31 | 2026-03-16 | — | — | $4.0M | +202768.8% |
| 2025-09-30 | 2025-11-12 | −$0.13 | — | $3.6M | — |
| 2025-06-30 | 2025-08-12 | −$0.36 | — | $163,616 | −95.2% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
